{"altmetric_id":1509012,"counts":{"readers":{"mendeley":13,"citeulike":0,"connotea":0},"facebook":{"unique_users_count":2,"unique_users":["100265333750","441078559301622"],"posts_count":2},"total":{"posts_count":2}},"citation":{"abstract":"This study evaluates the contribution of the individual components of an investigational non-\u03b2-antagonist fixed combination of brinzolamide, 1%, and brimonidine, 0.2%. This study and its sister study provide the first randomized data showing the intraocular pressure (IOP)-lowering activity and the toxicity profile of this novel topical antihypertensive fixed combination.","abstract_source":"pubmed","altmetric_jid":"53bd372b2a83eef6128b456a","authors":["Gregory Katz","Harvey DuBiner","John Samples","Steven Vold","Kenneth Sall"],"doi":"10.1001\/jamaophthalmol.2013.188","first_seen_on":"2013-05-25T18:57:34+00:00","issns":["2168-6165"],"journal":"JAMA Ophthalmology","last_mentioned_on":1366212950,"links":["http:\/\/archopht.jamanetwork.com\/article.aspx?articleID=1678149&utm_source=dlvr.it&utm_medium=facebook"],"pdf_url":"http:\/\/archopht.jamanetwork.com\/data\/Journals\/OPHTH\/0\/jamaophthalmol.2013.188.pdf","pmid":"23579344","pubdate":"2013-01-01T00:00:00+00:00","subjects":["ophthalmology"],"title":"Three-Month Randomized Trial of Fixed-Combination Brinzolamide, 1%, and Brimonidine, 0.2%","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/threemonth-randomized-trial-fixedcombination-brinzolamide-1-brimonidine-02"},"altmetric_score":{"score":0.5,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":0.5},"context_for_score":{"all":{"total_number_of_other_articles":3635015,"mean":4.9193540767705,"rank":2740920,"this_scored_higher_than_pct":20,"this_scored_higher_than":736112,"rank_type":"exact","sample_size":3635015,"percentile":20},"similar_age_3m":{"total_number_of_other_articles":85652,"mean":6.9531971138692,"rank":62436,"this_scored_higher_than_pct":21,"this_scored_higher_than":18339,"rank_type":"exact","sample_size":85652,"percentile":21},"this_journal":{"total_number_of_other_articles":816,"mean":5.2941938650307,"rank":769,"this_scored_higher_than_pct":5,"this_scored_higher_than":44,"rank_type":"exact","sample_size":816,"percentile":5},"similar_age_this_journal_3m":{"total_number_of_other_articles":24,"mean":1.6673913043478,"rank":18,"this_scored_higher_than_pct":20,"this_scored_higher_than":5,"rank_type":"exact","sample_size":24,"percentile":20}}},"demographics":{"users":{"mendeley":{"by_status":{"Professor > Associate Professor":1,"Researcher":4,"Other":3,"Student  > Master":2,"Student  > Bachelor":1,"Lecturer > Senior Lecturer":2},"by_discipline":{"Medicine and Dentistry":9,"Agricultural and Biological Sciences":3,"Biochemistry, Genetics and Molecular Biology":1}}}},"posts":{"facebook":[{"title":"Three-Month Randomized Trial of Fixed-Combination Brinzolamide, 1%, and Brimonidine, 0.2% Combinatio","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=594046317274887&id=100265333750","license":"public","citation_ids":[1509012],"posted_on":"2013-04-12T17:14:58+00:00","summary":"ImportanceThis study evaluates the contribution of the individual components of an investigational non\u2013\u03b2-antagonist fixed combination of brinzolamide, 1%, and brimonidine, 0.2%. This study and its sister study provide the first randomized data showing the","author":{"name":"JAMA Ophthalmology","url":"https:\/\/www.facebook.com\/100265333750","facebook_wall_name":"JAMA Ophthalmology","image":"https:\/\/graph.facebook.com\/100265333750\/picture","id_on_source":"100265333750"}},{"title":"http:\/\/archopht.jamanetwork.com\/article.aspx?articleid=1678149","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=456324161110395&id=441078559301622","license":"public","citation_ids":[1509012],"posted_on":"2013-04-17T15:35:50+00:00","summary":"#Oftalmolog\u00eda. La combinaci\u00f3n fija de #brinzolamida1%\/brimonidina0,2% present\u00f3 una eficacia reductora de la #PIO significativamente superior a la de sus componentes por separado. Un 19,5% de los pacientes incluidos en el estudio report\u00f3, al menos, un acont","author":{"name":"Ciencia y Deporte","url":"https:\/\/www.facebook.com\/441078559301622","facebook_wall_name":"Ciencia y Deporte","image":"https:\/\/graph.facebook.com\/441078559301622\/picture","id_on_source":"441078559301622"}}]}}